Search

everythinglearnresearchcommunity

for

Search:↓

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Scalp psoriasis inflammation is mainly caused by bacteria-related triggers.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Keratosis pilaris is often linked to genetic mutations and causes skin and hair abnormalities, regardless of those mutations.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

Doctors need more training in skin cancer screening, a new treatment is effective for a skin condition, better diagnosis methods for skin cancer are available, hair loss in women may be linked to hormones and cholesterol, certain skin care products might cause hair loss, babies' skin gets weaker after birth, and a gene mutation might be linked to eczema.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Vitiligo and alopecia areata may have similar causes despite their differences.